Clinical trials
Prematurity clinical trials
Below are recruiting prematurity clinical trials, each written for real people, not researchers. We’re tracking 257 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06797219Recruiting
Light therapy device study for newborns with severe brain bleeding
This trial tests a light therapy device in newborns who had a severe form of brain bleeding (intraventricular hemorrhage grade 3 or 4) within the first month of life. The goal is to see if this non-invasive treatment may help improve recovery.
Newark, New JerseyAges birth–1 month - NCT06717412Recruiting
Low-dose conbercept for retinopathy of prematurity
This trial tests whether a low dose of conbercept, given as an eye injection, can safely treat type 1 ROP (an eye disease in premature babies). The goal is to stop abnormal blood vessel growth and prevent vision loss.
Xi'an, ShaanxiAges Any age - NCT06688695Recruiting
Parent support for preterm infant development using e-health
This trial uses a special program to help parents of preterm babies learned responsive parenting through an e-health tool. It aims to support your baby's brain development by giving you practical tips and guidance from home.
Falun, Dalarna CountyAges birth–4 months - NCT06612541Recruiting
Eye imaging test for premature babies at risk of ROP
This study tests a new eye imaging device to check for retinopathy of prematurity (ROP), a condition that can affect vision in premature babies. It may help doctors diagnose ROP earlier and more easily at the bedside.
Nashville, TennesseeAges 6 months–8 months - NCT06518603RecruitingPhase 4
Caffeine for preventing apnea in preterm babies in Zambia
This trial tests whether giving caffeine citrate can help prevent breathing pauses (apnea) in preterm babies who are ready to stop their current caffeine treatment. It aims to see if a short course of caffeine can keep babies stable after they come off oxygen and are eating well.
Lusaka, Lusaka ProvinceAges birth–1 year - NCT06315556Recruiting
Study of Eylea for preterm babies with retinopathy of prematurity in the UK
This study collects information on how the medicine Eylea is given to preterm babies with retinopathy of prematurity (an eye problem in premature infants) using a special dosing device. The goal is to see how the treatment works in everyday hospital care.
Multiple LocationsAges Up to 1 year - NCT06200662Recruiting
Maternal Comfort for Pain Relief During Blood Draw in Preemies
This study tests whether a mother's comforting actions (like holding, talking, or breastfeeding) can reduce pain in very premature babies during a blood draw. It may help your baby feel less pain without extra medicine.
Strasbourg, Bas-RhinAges 7 months–8 months - NCT06164730RecruitingPhase 1
Study of VERVE-102 for high cholesterol or early heart disease
This trial tests a new medicine called VERVE-102 for people with a specific type of high cholesterol (HeFH) or early coronary artery disease. It aims to see if it can help lower cholesterol levels.
Dothan, AlabamaAges 18–70 - NCT06067529Recruiting
Study on the health effects of early menopause
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
Hangzhou, ZhejiangAges 10–65 - NCT04167033Recruiting
Checking heart rhythm timing in women with premature ovarian insufficiency
This study measures how quickly the heart “recharges” between beats (often shown as QT timing). It compares women with premature ovarian insufficiency to healthy women to understand whether ovarian insufficiency is linked to heart rhythm differences.
BordeauxAges 18–40 - NCT05340582RecruitingPhase 2
Ibuprofen plus acetaminophen for a heart condition in very premature babies
This Phase 2 study tests whether giving ibuprofen together with acetaminophen improves outcomes for an important heart connection (PDA) in extremely premature infants. It compares how this medicine approach affects the baby’s heart-related measurements and short-term progress.
Newcastle, New South WalesAges Up to 6 months - NCT05264779Recruiting
Decision help tool for very early delivery planning
This study tests a decision-support tool (a structured way to guide conversations) for parents facing a high risk of delivering very early (about 22–26 weeks). It may help you and your baby’s care team make clearer, more aligned choices about neonatal (newborn) treatment.
San Diego, CaliforniaAges 18 years+ - NCT05011071Enrolling by invitation
Alberta BLOOM study for very premature newborns
This study follows babies born very early and their parents to learn about early health and development. It may help doctors better understand what babies need after a premature birth.
Calgary, AlbertaAges birth+ - NCT04995341Recruiting
School-age follow-up study for premature babies’ eye health
This study looks at eye structure in children who were in an earlier premature-baby eye study and are now around 4.5–5 years old. It may help researchers better understand how eye disease in prematurity develops and how to monitor it.
Durham, North CarolinaAges Any age - NCT04439370Recruiting
Blood pressure control study in women with early menopause
This study looks at how the body automatically regulates blood pressure in women who went through menopause earlier than expected. It may help researchers understand whether early menopause affects blood pressure control and related health risks.
Minneapolis, MinnesotaAges 35–70 - NCT03218137RecruitingPhase 4
Adenosine test during heart procedure for frequent PVCs
This trial studies how a drug called adenosine helps doctors understand why premature ventricular contractions (PVCs) are happening. The goal is to guide treatment, including catheter ablation, for people with PVCs.
New York, New YorkAges 18–70 - NCT03083431RecruitingPhase 2
Oral propranolol to prevent early retinopathy in preemies
This trial tests whether giving propranolol by mouth to certain very premature babies with early eye changes can stop retinopathy of prematurity from getting worse. It may help reduce the need for eye treatments later on.
Tübingen, Baden-WurttembergAges 1 month–3 months - NCT02601339Recruiting
NIRS monitoring in premature babies with brain fluid problems
This study uses a special light-based monitor (NIRS) to track blood flow in the brain of premature infants. It compares babies in different conditions related to bleeding, fluid buildup, or other brain fluid changes to help doctors understand what monitoring can show.
Boston, MassachusettsAges birth–1 year - NCT05347238Recruiting
Dopamine or norepinephrine for low blood pressure in very preterm babies
This trial compares two common medicines—dopamine versus norepinephrine—to treat low blood pressure in very preterm babies who have suspected or confirmed late-onset bloodstream infection (sepsis). It may help doctors find which medicine works better and more safely for this specific situation.
Phoenix, ArizonaAges 5 months–7 months - NCT03019692Recruiting
Long-term follow-up for babies with brain bleeding
This study follows newborns and premature babies who had bleeding in the brain (intra-cranial or within the brain’s fluid spaces). It looks at long-term outcomes to better understand what happens over time and support families with care planning.
Netanya, IsraelAges 1 hour–3 months - NCT05017389Recruiting
Long-term health follow-up for premature newborns
This study follows babies born early (premature) over the long term to learn how they grow and develop. It mainly helps doctors understand long-term health needs after early birth.
Shanghai, Shanghai MunicipalityAges 2 weeks–4 months - NCT05207852Recruiting
Dexamethasone study for preterm labor lung development
This trial studies how well dexamethasone works and how it behaves in the body when given during preterm labor to help the baby’s lungs mature. You may be able to join if you’re pregnant between 24–36 weeks and are receiving the study treatment per their schedule.
BeijingAges 20–40 - NCT02744365Recruiting
Pregnancy complications biobank for future research
This study collects pregnancy-related samples and health information to help researchers learn more about conditions like preeclampsia and prematurity. Your participation may help future studies, but it usually involves whether you can safely consent and whether the pregnancy is continuing at the time of recruitment.
QuébecAges 18 years+ - NCT04420156Recruiting
Study to understand eye disease risk in premature babies
This study looks at newborn eye exams and genetic information to better understand why some premature infants develop a serious vision problem called ROP. You may be invited because your baby needs routine eye screening or is being moved for specialized eye care.
Palo Alto, CaliforniaAges Up to 1 year
Hear when a new Prematurity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prematurity?
- Yes. Clin2 currently lists 257 recruiting prematurity studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prematurity trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prematurity trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.